These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

560 related items for PubMed ID: 15565299

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prediction of response to risperidone treatment with respect to plasma concencentrations of risperidone, catecholamine metabolites, and polymorphism of cytochrome P450 2D6.
    Kakihara S, Yoshimura R, Shinkai K, Matsumoto C, Goto M, Kaji K, Yamada Y, Ueda N, Ohmori O, Nakamura J.
    Int Clin Psychopharmacol; 2005 Mar; 20(2):71-8. PubMed ID: 15729081
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The role of CYP2D6 and ABCB1 pharmacogenetics in drug-naïve patients with first-episode schizophrenia treated with risperidone.
    Jovanović N, Božina N, Lovrić M, Medved V, Jakovljević M, Peleš AM.
    Eur J Clin Pharmacol; 2010 Nov; 66(11):1109-17. PubMed ID: 20563569
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Jung SM, Kim KA, Cho HK, Jung IG, Park PW, Byun WT, Park JY.
    Clin Pharmacol Ther; 2005 Nov; 78(5):520-8. PubMed ID: 16321618
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L, Yu L, Zhang AP, Fang C, Du J, Gu NF, Qin SY, Feng GY, Li XW, Xing QH, He L.
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [Abstract] [Full Text] [Related]

  • 10. A six month randomized controlled trial of long acting injectable risperidone 50 and 100mg in treatment resistant schizophrenia.
    Meltzer HY, Lindenmayer JP, Kwentus J, Share DB, Johnson R, Jayathilake K.
    Schizophr Res; 2014 Apr; 154(1-3):14-22. PubMed ID: 24630262
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ABCB1 polymorphisms influence steady-state plasma levels of 9-hydroxyrisperidone and risperidone active moiety.
    Gunes A, Spina E, Dahl ML, Scordo MG.
    Ther Drug Monit; 2008 Oct; 30(5):628-33. PubMed ID: 18708991
    [Abstract] [Full Text] [Related]

  • 13. Serum concentrations and side effects in psychiatric patients during risperidone therapy.
    Olesen OV, Licht RW, Thomsen E, Bruun T, Viftrup JE, Linnet K.
    Ther Drug Monit; 1998 Aug; 20(4):380-4. PubMed ID: 9712460
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma pharmacokinetic characteristics of risperidone and their relationship to saliva concentrations in children with psychiatric or neurodevelopmental disorders.
    Aman MG, Vinks AA, Remmerie B, Mannaert E, Ramadan Y, Masty J, Lindsay RL, Malone K.
    Clin Ther; 2007 Jul; 29(7):1476-86. PubMed ID: 17825699
    [Abstract] [Full Text] [Related]

  • 18. Impact of Ageing on Serum Concentrations of Risperidone and Its Active Metabolite in Patients with Known CYP2D6 Genotype.
    Molden E, Waade RB, Hoff M, Haslemo T.
    Basic Clin Pharmacol Toxicol; 2016 Nov; 119(5):470-475. PubMed ID: 27145399
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Relationship between risperidone and 9-hydroxy-risperidone plasma concentrations and CYP2D6 enzyme activity in psychiatric patients.
    Berecz R, LLerena A, de la Rubia A, Gómez J, Kellermann M, Dorado P, Degrell I.
    Pharmacopsychiatry; 2002 Nov; 35(6):231-4. PubMed ID: 12518271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.